ALKS Return on Tangible Equity | Alkermes plc.

Alkermes plc. (ALKS) Return on Tangible Equity

2026-06-30: Return Tang Equity 5.45%.
2026-03-31: Return Tang Equity 13.23%.
2025-12-31: Return Tang Equity 13.93%.
2025-09-30: Return Tang Equity 20.54%.

Complete source-backed return tang equity history.

Available history: 2010-03-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	5.45%
2026-03-31	13.23%
2025-12-31	13.93%
2025-09-30	20.54%
2025-06-30	22.62%
2025-03-31	24.71%
2024-12-31	26.58%
2024-09-30	27.59%
2024-06-30	24.06%
2024-03-31	37.11%
2023-12-31	31.83%
2023-09-30	17.15%
2023-06-30	8.82%
2023-03-31	-18.58%
2022-12-31	-17.15%
2022-09-30	-14.30%
2022-06-30	-10.09%
2022-03-31	-6.72%
2021-12-31	-5.09%
2021-09-30	-9.97%
2021-06-30	-6.89%
2021-03-31	-11.05%
2020-12-31	-12.85%
2020-09-30	-8.45%
2020-06-30	-15.07%
2020-03-31	-16.75%
2019-12-31	-23.35%
2019-09-30	-24.68%
2019-06-30	-22.06%
2019-03-31	-20.91%
2018-12-31	-15.70%
2018-09-30	-16.39%
2018-06-30	-16.78%
2018-03-31	-21.56%
2017-12-31	-15.94%
2017-09-30	-23.06%
2017-03-31	-20.49%
2016-12-31	-15.23%
2012-03-31	-79.24%
2011-12-31	-7.70%
2011-09-30	-6.76%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	13.93%
2024-12-31	26.58%
2023-12-31	31.83%
2022-12-31	-17.15%
2021-12-31	-5.09%
2020-12-31	-12.85%
2019-12-31	-23.35%
2018-12-31	-15.70%
2017-12-31	-18.50%
2016-12-31	-26.11%
2015-12-31	-26.97%
2014-12-31	-3.65%
2013-03-31	8.81%
2012-03-31	-79.35%
2011-03-31	-11.62%
2010-03-31	-9.60%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)	United States	$6.771B	-37.20
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
Liquidia Corp (LQDA)	United States	$6.347B	51.23
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Spyre Therapeutics, Inc. (SYRE)	United States	$7.685B	-43.69
Structure Therapeutics Inc. (GPCR)	United States	$7.710B	-53.41
Praxis Precision Medicines, Inc. (PRAX)	United States	$7.884B	-27.60
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76